JDRF has seen tremendous legislative and regulatory victories in recent years on behalf of the millions of people living with type 1 diabetes (T1D). And in a political environment crowded with important issues and a strained fiscal climate, all of those victories were hard won. JDRF has its champions in Congress to thank for their [...]
JDRF has seen tremendous legislative and regulatory victories in recent years on behalf of the millions of people living with type 1 diabetes (T1D). And in a political environment crowded with other important issues and a strained fiscal climate, all of those victories were hard won. JDRF has its champions in Congress to thank for [...]
In 1983, a trial began that would forever alter the standard of management of type 1 diabetes (T1D) and serve as a stepping stone to future research advances—and as we mark the 30th anniversary of the trial’s inception, we are still learning from the study. The Diabetes Control and Complications Trial (DCCT), a 10-year multicenter [...]
Earlier this year—and with your support—JDRF was delighted to help secure a one-year renewal of the Special Diabetes Program (SDP) that was included in the ‘American Taxpayer Relief Act of 2012’ legislation, which passed Congress over the New Year’s Eve holiday. Please take a moment today to thank legislators who supported T1D research over the [...]
On January 1, 2013, JDRF had an extra reason to celebrate the New Year when the United States Congress passed a one-year renewal of the Special Diabetes Program (SDP). Thanks to JDRF advocates, volunteers, and staff, the National Institutes of Health will receive an additional $150 million specifically for type 1 diabetes (T1D) research. The [...]
(reprinted from The Wall Street Journal) While most people know me as owner of the New York Jets, my passion has long been in a different field: finding a cure for diabetes, one of America’s most devastating diseases. Researchers are on the verge of achieving once-unthinkable goals in the battle against diabetes that will improve [...]
The Special Diabetes Program: Its successful history and crucial future By Talley Henning Brown This fall, JDRF and the type 1 diabetes (T1D) community have a special opportunity to make legislative history once again—by persuading the 112th Congress to renew the Special Diabetes Program (SDP). Funds provided by the SDP have supported advances in the [...]
The Special Diabetes Program (SDP) of the National Institutes of Health was established in 1997. The SDP is a key component of the federal government’s commitment to type 1 diabetes (T1D) research. There are two parts of the program: the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians. In the [...]
Congress passed the Special Diabetes Program (SDP) in December 2010, committing $150 million per year to extend the program for an additional two years. The legislation marks the fifth time since 1997 that Congress has supported SDP, underscoring the government’s commitment to accelerating the search for a cure and the development of new treatments for [...]
On August 3, JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust, announced the award of a $4.6 million grant to the laboratory of Camillo Ricordi, M.D., of the Diabetes Research Institute at the University of Miami. The three-year grant will fund research in the area of beta cell encapsulation, a [...]
